10x Insights
Loading account…
Companies / Technology / Doximity, Inc.
DOCS

Doximity, Inc.

TechnologyComputer Services
Ticker DOCSSAN FRANCISCO, CAFiscal year ends MarchBook value per share $4.79Diluted shares 191.2M

Doximity, Inc. (NYSE: DOXI) operates as the leading physician-first technology platform in the United States, serving over 3 million registered members representing more than 85% of U.S. physicians across all 50 states and every medical specialty. The company's website is www.doximity.com. From the company’s description.

Fiscal year 2026 · ends 03-31Changes are against fiscal 2025The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
$644.86M
+13.1% year over year
Last 12 mo $655.57M
33.33%
−6.6 percentage points
Last 12 mo 29.60%
$196.05M
−12.2% year over year
Last 12 mo $167.05M
20.62%
−0.2 percentage points
Last 12 mo 18.24%
Cash & financing
$326.46M
+19.5% year over year
Last 12 mo $306.34M
$317.56M
+19.1% year over year
Last 12 mo $297.03M
—
199.0M
−1.1% year over year
Last 12 mo 191.2M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What Doximity, Inc. does

In the company’s own words

Doximity, Inc. (NYSE: DOXI) operates as the leading physician-first technology platform in the United States, serving over 3 million registered members representing more than 85% of U.S. physicians across all 50 states and every medical specialty. The company's website is www.doximity.com.

The platform provides free access to U.S. medical professionals including physicians, nurse practitioners, physician assistants, and medical students. Doximity's core offerings span three primary business segments: Marketing Solutions, Hiring Solutions, and Workflow Solutions. Marketing Solutions enable pharmaceutical manufacturers and health systems to deliver targeted sponsored content to medical professionals through various modules including newsfeed placements, workflow integrations, and peer-to-peer messaging. Hiring Solutions provide digital recruiting capabilities allowing health systems and recruiting firms to identify and connect with medical professionals, supplemented by Curative Talent, a personalized staffing firm combining data science with healthcare recruitment expertise. Workflow Solutions comprise AI-powered clinical tools including Dialer for telehealth, Scribe for ambient AI documentation, Ask for evidence-based clinical assistance, secure messaging, fax services, and on-call scheduling through the AMiON platform.

The company's technology platform leverages an extensive database of physician information combined with proprietary machine learning methodologies to deliver personalized content and targeted marketing capabilities. The platform benefits from powerful network effects, as expanding membership increases value for both medical professionals and customers seeking to engage healthcare providers. Doximity's Clinical AI Suite integrates Ask, Scribe, and Dialer into a unified workflow adopted by more than 140 leading U.S. health systems.

As of March 31, 2026, Doximity employed 880 full-time equivalent employees, with more than one-third working in research and development including product, engineering, and data functions. The company operates a geographically distributed workforce supplemented by contractors and consultants. Revenue derives predominantly from subscription-based arrangements with pharmaceutical manufacturers, health systems, medical recruiting firms, and other healthcare organizations. The platform's physician-first design philosophy and clinical expertise form core competitive advantages, enabling Doximity to address unique workflow needs of healthcare professionals while maintaining trust through HIPAA-compliant communications and verified credential verification.

Company details
Sector
Technology
Industry
Computer Services
Headquarters
SAN FRANCISCO, CA
Fiscal year end
March
CIK
1516513
SIC
7371

Financial performance, year by year

Fiscal 2022–2026 · USD
$-65.56M$131.11M$327.78M$524.45M$721.12M20222023202420252026Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns Doximity, Inc. — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

310
funds hold it
1 of 35
superinvestors hold it
$957.17M
held by funds, at market
24.3%
of shares held by funds

Superinvestors in Doximity, Inc. · what they did last quarter

Terry SmithDECREASED -5.6%
Fundsmith
0.1%of 13F portfolio

Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.

Largest fund holders · Doximity, Inc.’s weight in each

iShares Core S&P Mid-Cap ETF
IJH · iShares Trust
0.08%of fund net assets
0.43%of fund net assets
VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
VANGUARD SMALL-CAP INDEX FUND
VB · VANGUARD INDEX FUNDS
0.03%of fund net assets
Federated Hermes MDT Mid Cap Growth Fund
FGSAX · Federated Hermes Equity Funds
0.59%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.

Could not be determined for this company: bond issues.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do Doximity, Inc. and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of Doximity, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in Doximity, Inc.'s last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.